Seeking Alpha

Roche Holdings AG Basel (RHHBY.PK)

()

News & PR
Market Currents

Buzz
Twitter: RHHBY.PK

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

European Shares at 15-Month High

Dec 28 • The LFB • Comment!
Making and Breaking Biotech Deals

Dec 14 • The Burrill Report • Comment!
Biotech's Latest Failed Trials, Missed Targets

Dec 14 • The Burrill Report • 1 Comment
December's Game Plan for Biotech

Dec 1 • Justin M. Hall • 4 Comments
Immunogen's Busy Month, Part I

Dec 1 • Ohad Hammer • Comment!
Health Care Takes Bigger Slice of Risk Capital

Nov 30 • Sydney Williams • Comment!
Spectrum Pharma: Zevalin Sales Ramp Up

Nov 22 • Justin M. Hall • 23 Comments
Diabetes Care: Global Investing Opportunities

Nov 22 • Mike Havrilla • 4 Comments
Are Markets Headed for an 800-Point Blow-Off Day?

Nov 12 • Joseph L. Shaefer • 25 Comments
Week in Review: Major Investments in China Biotech Companies

Nov 8 • ChinaBio Today • 1 Comment
Roche Opens Singapore Manufacturing Facility for Projects Initiated by Genentech

Nov 5 • ChinaBio Today • Comment!
Spectrum Pharma: CMS Rules in Favor of Zevalin

Nov 3 • Justin M. Hall • 6 Comments
Healthcare Profits: Assessing Company Sensitivity to Obamacare

Oct 30 • Richard Shaw • 11 Comments
ImmunoCellular's Promising Brain Cancer Vaccine

Oct 28 • Mike Havrilla • 2 Comments
Spectrum Pharma: Zevalin Has Blockbuster Potential

Oct 25 • Justin M. Hall • 36 Comments
Little Difference Between Roche's Avastin and Lucentis for Macular Degeneration

Oct 18 • The Burrill Report • 3 Comments
Extraordinary Popular Delusions and the Madness of Crowds

Oct 14 • Joseph L. Shaefer • 21 Comments
M&A Watch: 8 Medical Consumables Companies That Look Like Buyout Targets

Oct 11 • Alan Brochstein • 7 Comments
Immunomedics Gets a Lot of Things Right

Oct 3 • EP Vantage • Comment!
Climate Change: How to Invest for the Possibility

Sep 25 • Joseph L. Shaefer • 37 Comments
Pundits Are Wrong: Healthcare Reform Will Increase Profits

Sep 17 • Todd Campbell • 24 Comments
ImmunoCellular: What's Next After Roche Deal?

Sep 14 • Mike Havrilla • 1 Comment
ImmunoCellular: Roche Pact Validates Pipeline Potential

Sep 9 • Mike Havrilla • 2 Comments
Small Cap Stocks Battling Brain Cancer

Sep 7 • Mike Havrilla • 4 Comments
Summer Ends with Biotech Buying Spree

Sep 6 • The Burrill Report • Comment!
Report from Europe: U.S. Close vs. China Rebound

Sep 3 • The Mole • 4 Comments
Emerging Economies: The Good, The Bad and The Ugly

Aug 25 • Joseph L. Shaefer • 11 Comments
Genmab Punished as Arzerra Stumbles in Pivotal Trial - Glaxo Also Affected

Aug 18 • EP Vantage • 1 Comment
3 Biotechs, 3 Big Pharma Plays for the Coming Generics Boom

Aug 18 • The Curious Investor • 4 Comments
Biotech Stocks: Digging for Gold in a Swine's Snout

Aug 2 • Jay Garcilazo • 2 Comments
FDA Calendar Updates: Achillion Pharma, Roche, Genzyme, Protalix, Shire

Jul 31 • Mike Havrilla • Comment!
FDA Calendar Updates: United Therapeutics, Roche

Jul 30 • Mike Havrilla • Comment!
Lines Blur Between Biotech and Pharma

Jul 28 • Vincent Fernando • Comment!
Too Late to Board the Biotech Bandwagon?

Jul 28 • Sam Subramanian • 5 Comments
Preview from Europe: Nasdaq Continues Winning Streak, But Dow Disappoints

Jul 23 • The Mole • 2 Comments
Spectrum Pharmaceuticals and Zevalin: The Importance of FDA Approval

Jul 19 • Justin M. Hall • 2 Comments
Access Pharma: Deep Pipeline, Shallow Valuation

Jul 15 • Mike Havrilla • 2 Comments
Pfizer Might Achieve Goal of Becoming Number 3 in Oncology, But Needs Heftier Sales

Jul 14 • EP Vantage • Comment!
FDA Calendar Updates: BioMarin, OSI, Roche, Abraxis, Johnson & Johnson

Jul 14 • Mike Havrilla • Comment!
Swine Flu Vaccines Will Have to Wait

Jul 14 • David White • 4 Comments
Curagen: Positive Results at ASCO 2009

Jul 7 • Ohad Hammer • 2 Comments

Roche Holdings AG Basel (RHHBY.PK)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers